NT5E and cancer: Moreover, it has been extensively shown that inhibiting CD73 may directly improve outcomes of conventional therapies by directly targeting cancer cells or by decreasing adenosine levels and, consequently, indirectly promoting antitumor-effector immune cells in the alleviation of the immunosuppressed microenvironment (Azambuja et al., 2019).